SEC Form 4 · accession 0000899243-17-004241
Ocugen, Inc. · OCGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Gridley
Officer — See Remarks · Director
Period of report
Feb 14, 2017
Accepted (ET)
Feb 15, 2017 · 6:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372299
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.72 | Feb 14, 2017 | A | 175,000 | A | — | Feb 14, 2027 | Common Stock | 175,000 | 175,000 | D |
Explanation of responses
- F1This option vests over four (4) years of service to the Issuer following February 14, 2017, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service to the Issuer following such date and the balance vesting in thirty-six (36) equal monthly installments thereafter.
Remarks
President and Chief Executive Officer